Implanet S.A. (ALIMP.PA)
0.1694 €
+0.00 (+0.12%)
Rating:
Recommendation:
-
| Symbol | ALIMP.PA |
|---|---|
| Price | 0.1694 € |
| Beta | 1.498 |
| Volume Avg. | 0.18M |
| Market Cap | 2.231M |
| Shares () | - |
| 52 Week Range | 0.12-0.837 |
| 1y Target Est | - |
| DCF Unlevered | ALIMP.PA DCF -> | |
|---|---|---|
| DCF Levered | ALIMP.PA LDCF -> | |
| ROE | -278.20% | Strong Sell |
| ROA | -24.67% | Sell |
| Operating Margin | - | |
| Debt / Equity | 495.72% | Strong Buy |
| P/E | - | |
| P/B | 0.07 | Neutral |
About
Download (Excel)Implanet S.A., together with its subsidiaries, researches and develops, manufactures, and sells spinal and orthopedic implants. The company offers spinal and knee products. Its products include Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Jazz Frame, and ISS-Jazz Screw systems for posterior fixation. The company also provides knee prostheses under the Madison name. Implanet S.A. has a strategic partnership with Shanghai Sanyou Medical Co, Ltd. The company was founded in 2006 and is based in Martillac, France.